Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

SNTI

SNTI News

Newswire

09:02

Senti Biosciences to host conference call on updated clinical results from SENTI-202.

21:31

Leerink Partners Initiates Coverage of Senti Biosciences with Outperform Recommendation, Analyst Price Forecast Suggests 632.60% Upside.

09:49

Senti Biosciences: Leerink Partners initiates coverage at Outperform with $6 PT.

16:31

Senti Bio Reports Q3 2025 Financials, Confirms Next Clinical Data Readout for Phase 1 SENTI-202 Study in Acute Myeloid Leukemia at ASH Annual Meeting in December

09:09

Senti Bio reports positive AML clinical results, durable remission rates, and strong safety profile.

View More

About SNTI

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More